A recent study (NORDIC Study Group et al., 2014) examined the treatment of IIH with acetazolamide, a carbonic anhydrase inhibitor that is thought to reduce intracranial pressure in part by ...
In addition to probably mild malnutrition (albumin 3.3 g/dL; normal range, 3.5 to 5.0 g/dL), the patient had no identifiable risk factors, except for having received acetazolamide. The patient had ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback